Helicobacter pylori Is Associated with miR-133a Expression through Promoter Methylation in Gastric Carcinogenesis
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: To investigate whether Helicobacter pylori eradication can reverse epigenetic silencing of microRNAs (miRNAs) which are associated with H. pylori-induced gastric carcinogenesis. Methods: We examined expression and promoter methylation of miR-34b/c, miR-133a, let-7a, and let-7i in gastric cancer cell line, before/after demethylation. Among them, epigenetically controlled miRNAs were identified. Their expression and promoter methylation was examined in human tissues of H. pylori-positive gastric cancer (T), H. pylori-positive gastritis (H), and H. pylori-negative controls (C). We also compared changes of miRNA expression and promoter methylation in H. pylori-positive patients who were endoscopically treated for early gastric cancer, between baseline and 1 year later according to eradication status. Results: In gastric cancer cell line, miR-34b/c and miR-133a showed epigenetic silencing. In human tissues, miR-34b/c and miR-133a showed serial increase of promoter methylation in order of C, H, and T (all, p<0.01), and the miR-133a expression showed serial decrease (C vs H, p=0.02; H vs T, p=0.01; C vs T, p<0.01) while miR-34b and miR-34c expressions did not. H. pylori eradication induced decrease of methylation (p<0.01) and increase of miR-133a expression (p=0.03), compared with noneradication group. Conclusions: This result suggests H. pylori eradication could reverse methylation-silencing of miR-133a which is involved in H. pylori-induced gastric carcinogenesis.
Abstract
Background/Aims: To investigate whether Helicobacter pylori eradication can reverse epigenetic silencing of microRNAs (miRNAs) which are associated with H. pylori-induced gastric carcinogenesis. Methods: We examined expression and promoter methylation of miR-34b/c, miR-133a, let-7a, and let-7i in gastric cancer cell line, before/after demethylation. Among them, epigenetically controlled miRNAs were identified. Their expression and promoter methylation was examined in human tissues of H. pylori-positive gastric cancer (T), H. pylori-positive gastritis (H), and H. pylori-negative controls (C). We also compared changes of miRNA expression and promoter methylation in H. pylori-positive patients who were endoscopically treated for early gastric cancer, between baseline and 1 year later according to eradication status. Results: In gastric cancer cell line, miR-34b/c and miR-133a showed epigenetic silencing. In human tissues, miR-34b/c and miR-133a showed serial increase of promoter methylation in order of C, H, and T (all, p<0.01), and the miR-133a expression showed serial decrease (C vs H, p=0.02; H vs T, p=0.01; C vs T, p<0.01) while miR-34b and miR-34c expressions did not. H. pylori eradication induced decrease of methylation (p<0.01) and increase of miR-133a expression (p=0.03), compared with noneradication group. Conclusions: This result suggests H. pylori eradication could reverse methylation-silencing of miR-133a which is involved in H. pylori-induced gastric carcinogenesis.
참고문헌 (37)
- Ambros V, "MicroRNAs: tiny regulators with great potential", Cell, 107, pp.823~826 (2001)[DOI]
- Yamamichi N, "Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development", Clin Cancer Res, 15, pp.4009~4016 (2009)[DOI]
- Zhang Z, "miR-21 plays a pivotal role in gastric cancer pathogenesis and progression", Lab Invest, 88, pp.1358~1366 (2008)[DOI]
- Liu T, "MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin", Cancer Lett, 273, pp.233~242 (2009)[DOI]
- Nervi C, "Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis", Epigenetics, 3, pp.1~4 (2008)[DOI]
- Ando T, "DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect", Int J Cancer, 124, pp.2367~2374 (2009)[DOI]
- Suzuki H, "Methylation-associated silencing of microRNA-34b", c in gastric cancer and its involvement in an epigenetic field defect, 2010, pp.31, 2066~2073
- Hayashi Y, "CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis", Gut, 62, pp.1536~1546 (2013)[DOI]
- Toyota M, "Epigenetic silencing of microRNA-34b", c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer, 2008, pp.68, 4123~4132
- Suzuki R, "Aberrant methylation of microRNA-34b", c is a predictive marker of metachronous gastric cancer risk, 2014, pp.49, 1135~1144
- Reinhart BJ, "The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans", Nature, 403, pp.901~906 (2000)[DOI]
- Esquela-Kerscher A, "Oncomirs: microRNAs with a role in cancer", Nat Rev Cancer, 6, pp.259~269 (2006)[DOI]
- Saito Y, "Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice", Gastroenterology, 140, pp.189~198 (2011)[DOI]
- Qiu T, "miR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer", FEBS Lett, 588, pp.1168~1177 (2014)[DOI]
- Gong Y, "Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R", World J Gastroenterol, 21, pp.2949~2958 (2015)[DOI]
- Liu Y, "Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b", a-3p as therapeutic target for gastric cancer, 2015, pp.369, 58~66
- Li C, "MicroRNA-133a inhibits proliferation of gastric cancer cells by downregulating ERBB2 expression", Oncol Res, 25, pp.1169~1176 (2017)[DOI]
- Dixon MF, "Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) Method", Methods, 25, pp.402~408 (2001)[DOI]
- Park SY, "Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection", J Pathol, 219, pp.410~416 (2009)[DOI]
- Eads CA, "MethyLight: a high-throughput assay to measure DNA methylation", Nucleic Acids Res, 28, pp.E32~ (2000)[DOI]
- Ogino S, "Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis", J Mol Diagn, 8, pp.209~217 (2006)[DOI]
- Chiyomaru T, "miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer", Br J Cancer, 102, pp.883~891 (2010)[DOI]
- Kinoshita T, "Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma", Biochem Biophys Res Commun, 418, pp.378~383 (2012)[DOI]
- Moriya Y, "Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma", J Hum Genet, 57, pp.38~45 (2012)[DOI]
- Kojima S, "Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer", Br J Cancer, 106, pp.405~413 (2012)[DOI]
- Dong Y, "Tumor suppressor functions of miR-133a in colorectal cancer", Mol Cancer Res, 11, pp.1051~1060 (2013)[DOI]
- Wang LK, "MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma", PLoS One, 9, pp.e96765~ (2014)[DOI]
- Song X, "miR-133a inhibits cervical cancer growth by targeting EGFR", Oncol Rep, 34, pp.1573~1580 (2015)[DOI]
- Qin Y, "miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer", Oncol Res, 21, pp.353~363 (2013)
- Cui W, "MicroRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR", Akt signaling pathway, 2013, pp.280, 3962~3974
- Zhang W, "MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma", Tumour Biol, 36, pp.9779~9788 (2015)[DOI]
- Huang Y, "MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ", Am J Cancer Res, 6, pp.2448~2462 (2016)
- Chen WS, "Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer", Oncol Rep, 28, pp.1069~1076 (2012)[DOI]
- Huang L, "Phenanthrene exposure induces cardiac hypertrophy via reducing miR-133a expression by DNA methylation", Sci Rep, 6, pp.20105~ (2016)[DOI]
- Ramachandran K, "DNA methylation and field cancerization", Epigenomics, 4, pp.243~245 (2012)[DOI]
- Ushijima T, "Epigenetic field for cancerization: its cause and clinicalimplications", BMC Proc, 7(Suppl 2), pp.K22~ (2013)[DOI]
